T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery

Neurosurgery

Volumn 66, Issue 3, 2010, Pages 486-491

  Kano, Hideyuki ^a   Kondziolka, Douglas ^a   Lobato Polo, Javier ^a   Zorro, Oscar ^a   Flickinger, John C ^b   Lunsford, L Dade ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Cancer; Gamma knife; Imaging; Stereotactic radiosurgery

Indexed keywords

ANTINEOPLASTIC AGENT; METHYLPREDNISOLONE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; COURSE EVALUATION; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION RESPONSE; SENSITIVITY AND SPECIFICITY; STEREOTACTIC RADIOSURGERY; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; WHOLE BODY RADIATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; RADIOSURGERY; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 77649123080     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000360391.35749.A5     Document Type: Article

References (23)

1. Belohlávk O, Simonová G, Kantorová I, Novotný J Jr, Liscák R. Brain metastases after stereotactic radiosurgery using Leksell gamma knife: Can FDG PET help to differentiate radionecrosis from tumour progression? Eur J Nucl Med. 2003;30(1):96-100.
2. Terakawa Y, Tsuyuguchi N, Iwai Y, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49(5):694-699.
3. Tsuyuguchi N, Sunada I, Iwai Y, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: Is a differential diagnosis possible? J Neurosurg. 2003;98(5):1056-1064.
4. Noël G, Proudhom MA, Valery CA, et al. Radiosurgery for re-irradiation of brain metastasis: Results in 54 patients. Radiother Oncol. 2001;60(1):61-67.
5. Bhatnagar A, Heron DE, Kondziolka D, Lunsford LD, Flickinger JC. Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors. Int J Radiat Oncol Biol Phys. 2002;53(3):527-532.
6. Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH. Reoperation for recurrent metastatic brain tumors. J Neurosurg. 1995;83(4):600-604.
7. Sundaresan N, Sachdev VP, DiGiacinto GV, Hughes JE. Reoperation for brain metastases. J Clin Oncol. 1988;6(10):1625-1629.
8. Dequesada IM, Quisling RG, Yachnis A, Friedman WA. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery. 2008;63(5):898-904.
9. Plowman PN. Stereotactic radiosurgery: VIII. The classification of postradiation reactions. Br J Neurosurg. 1999;13(3):256-264.
10. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol. 1991;12(1):45-62.
11. Chin LS, Levy ML, Rabb CH, Chandrasoma PT, Zee CS, Apuzzo MJ. Principles and pitfalls of image directed stereotactic biopsy of brain lesions. In, Thomas DGT, ed. Stereotactic and Image Directed Surgery of Brain Tumours. New York: Churchill Livingstone; 1993:49-63.
12. Lunsford LD. Diagnosis and treatment of mass lesions using the Leksell stereotactic system. In, Lunsford LD, ed. Modern Stereotactic Neurosurgery. Boston: Nijhoff; 1988:45-168.
13. Apuzzo ML, Sabshin JK. Computed tomographic guidance stereotaxis in the management of intracranial mass lesions. Neurosurgery. 1983;12(3):277-285.
14. Kelly PJ. Tumor Stereotaxis. Philadelphia: W.B. Saunders; 1991.
15. Ashdown BC, Boyko OB, Uglietta JP, et al. Postradiation cerebellar necrosis mimicking tumor: MR appearance. J Comput Assist Tomogr. 1993;17(1):124-126.
16. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology. 1986;158(1):149-155.
17. Graeb DA, Steinbok P, Robertson WD. Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation. Radiology. 1982;144(4):813-817.
18. Griffeth LK, Rich KM, Dehdashti F, et al. Brain metastases from non-central nervous system tumors: Evaluation with PET. Radiology. 1993;186(1):37-44.
19. Thompson TP, Lunsford LD, Kondziolka D. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg. 1999;73(1-4):9-14, 1999.
20. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer. 2001;96(3):191-197.
21. Truong MT, St Clair EG, Donahue BR, et al. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery. 2006;59(1):86-97.
22. Erol FS, Topsakal C, Ozveren MF, et al. Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: An experimental study. Neurosurg Rev. 2004;27(1):65-69.
23. Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC. Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: A pilot study. Stereotact Funct Neurosurg. 2008;86(6):359-366.